AEZS

March 12, 2013 Aeterna Zentaris to Announce Fourth Quarter and Full Year 2012 Financial and Operating Results on March 21, 2013

[at noodls] – March 12, 2013 Aeterna Zentaris to Announce Fourth Quarter and Full Year 2012 Financial and Operating Results on March 21, 2013 Quebec City, Canada, March 12, 2013 – Aeterna Zentaris Inc. (NASDAQ: AEZS) … moreView todays social media effects on AEZSView the latest stocks trending across Twitter. Click to view dashboardSee who AEterna is hiring next, click […]

March 11, 2013 Aeterna Zentaris to Discontinue Phase 3 Trial in Multiple Myeloma with Perifosine Following Data Safety Monitoring Board Recommendation

[at noodls] – March 11, 2013 Aeterna Zentaris to Discontinue Phase 3 Trial in Multiple Myeloma with Perifosine Following Data Safety Monitoring Board Recommendation Quebec City, Canada, March 11, 2013 – Aeterna Zentaris … moreView todays social media effects on AEZSView the latest stocks trending across Twitter. Click to view dashboardSee who AEterna is hiring next, click here to view […]

December 28, 2012 Aeterna Zentaris Granted Special Protocol Assessment by the FDA for Phase 3 Registration Trial in Endometrial Cancer with AEZS-108

[at noodls] – December 28, 2012 Aeterna Zentaris Granted Special Protocol Assessment by the FDA for Phase 3 Registration Trial in Endometrial Cancer with AEZS-108 Québec City, Canada, December 28, 2012 – Aeterna Zentaris … moreView todays social media effects on AEZSView the latest stocks trending across Twitter. Click to view dashboardSee who AEterna is hiring next, click here to […]

December 11, 2012 Aeterna Zentaris: Final Phase 2 Data Demonstrate Perifosine and Sorafenib Combination Therapy Well Tolerated by Heavily Pretreated Lymphoma Patients

[at noodls] – December 11, 2012 Aeterna Zentaris: Final Phase 2 Data Demonstrate Perifosine and Sorafenib Combination Therapy Well Tolerated by Heavily Pretreated Lymphoma Patients Promising clinical response activity … moreView todays social media effects on AEZSView the latest stocks trending across Twitter. Click to view dashboardSee who AEterna is hiring next, click here to view […]

November 26, 2012 Aeterna Zentaris: Final Phase 2 Data for Perifosine in Lymphomas to be Presented at Upcoming ASH Meeting

[at noodls] – November 26, 2012 Aeterna Zentaris: Final Phase 2 Data for Perifosine in Lymphomas to be Presented at Upcoming ASH Meeting Québec City, Canada, November 26, 2012 – Aeterna Zentaris Inc. (NASDAQ: AEZS) … moreView todays social media effects on AEZSView the latest stocks trending across Twitter. Click to view dashboard […]

November 12, 2012 Aeterna Zentaris Announces Initiation of Phase 2 Portion of Phase 1/2 Trial with AEZS-108 in Prostate Cancer

[at noodls] – November 12, 2012 Aeterna Zentaris Announces Initiation of Phase 2 Portion of Phase 1/2 Trial with AEZS-108 in Prostate Cancer Québec City, Canada, November 12, 2012 – Aeterna Zentaris Inc. (NASDAQ: AEZS) … moreView todays social media effects on AEZSView the latest stocks trending across Twitter. Click to view dashboard […]

November 8, 2012 Aeterna Zentaris Presents Proof-of-Concept for Disorazol Z Cytotoxic Conjugates, such as AEZS-125, in Ovarian Cancer Mouse Model at ENA Symposium

[at noodls] – November 8, 2012 Aeterna Zentaris Presents Proof-of-Concept for Disorazol Z Cytotoxic Conjugates, such as AEZS-125, in Ovarian Cancer Mouse Model at ENA Symposium Québec City, Canada, November 8, 2012 … moreView todays social media effects on AEZSView the latest stocks trending across Twitter. Click to view dashboard […]

November 7, 2012 Aeterna Zentaris to Announce Third Quarter 2012 Financial and Operating Results on November 13, 2012

[at noodls] – November 7, 2012 Aeterna Zentaris to Announce Third Quarter 2012 Financial and Operating Results on November 13, 2012 Quebec City, Canada, November 7, 2012 – Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: … moreView todays social media effects on AEZSView the latest stocks trending across Twitter. Click to view dashboard […]

October 17, 2012 Aeterna Zentaris Announces Closing of US$16.5 Million Public Offering of Common Shares and Warrants

[at noodls] – October 17, 2012 Aeterna Zentaris Announces Closing of US$16.5 Million Public Offering of Common Shares and Warrants Québec City, Canada, October 17, 2012 – Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) … moreView todays social media effects on AEZSView the latest stocks trending across Twitter. Click to view dashboard […]

October 12, 2012 Aeterna Zentaris Announces Pricing of US$16.5 Million Public Offering of Common Shares and Warrants

[at noodls] – October 12, 2012 Aeterna Zentaris Announces Pricing of US$16.5 Million Public Offering of Common Shares and Warrants Québec City, Canada, October 12, 2012 – Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) … moreView todays social media effects on AEZSView the latest stocks trending across Twitter. Click to view dashboard […]